ZyVersa Therapeutics, Inc. — 10-Q Filings
12 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by ZyVersa Therapeutics, Inc. (ZVSA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ZyVersa Therapeutics, Inc. has filed 12 10-Q documents with the SEC since 2021. To view all SEC filings by ZyVersa Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001493152-25-024263 | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-023342 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-009724 | May 12, 2025 | Mar 31, 2025 |
| 10-Q | — | 0001493152-24-045351 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | — | 0001493152-24-031002 | Aug 9, 2024 | Jun 30, 2024 |
| 10-Q | — | 0001493152-24-019517 | May 15, 2024 | Mar 31, 2024 |
| 10-Q | — | 0001493152-23-041185 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | — | 0001493152-23-029603 | Aug 21, 2023 | Jun 30, 2023 |
| 10-Q | — | 0001493152-23-016480 | May 12, 2023 | Mar 31, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-072377 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-048196 | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-026061 | May 13, 2022 | Mar 31, 2022 |